To our understanding, this is the first report to elucidate the genomic diversity of CD209 gene promoter (snp-336A/G) polymorphisms in sickle cell disease, with the potential to clarify its role or otherwise in susceptibility to infectious pathogens between sickle cell disease and control groups. This evidence concerns the gene CD209 and sickle cell disease.